Skip to content
SEARCH
Investing
Tech
Application Software
Communications
Computer Hardware
Online Media
Semiconductors
Consumer
Autos
Beverages
Consumer Packaged Goods
Entertainment
Manufacturing
Restaurants
Retail
Travel & Leisure
Financial
Asset Management
Banks
Brokers & Exchanges
Credit Services
Insurance
Politics
Trump
US Budget
Health
Healthcare
Biotechnology
Drug Manufacturers
Pharmaceutical
Basic Materials
Agriculture
Metals & Mining
Cobalt
Zinc
Gold
Silver
Lithium
Uranium
Copper
Energy
Oil & Gas
Alternative Energy
Biofuels
Hydro
Solar
Industrials
Aerospace and Defense
Airlines
Business Services
Consulting and Outsourcing
Farm & Construction Machinery
Industrial Products
Transportation & Logistics
Search
SEARCH FOR AN ARTICLE
Search
Search
Investing
Tech
Application Software
Communications
Computer Hardware
Online Media
Semiconductors
Consumer
Autos
Beverages
Consumer Packaged Goods
Entertainment
Manufacturing
Restaurants
Retail
Travel & Leisure
Financial
Asset Management
Banks
Brokers & Exchanges
Credit Services
Insurance
Politics
Trump
US Budget
Health
Healthcare
Biotechnology
Drug Manufacturers
Pharmaceutical
Basic Materials
Agriculture
Metals & Mining
Cobalt
Zinc
Gold
Silver
Lithium
Uranium
Copper
Energy
Oil & Gas
Alternative Energy
Biofuels
Hydro
Solar
Industrials
Aerospace and Defense
Airlines
Business Services
Consulting and Outsourcing
Farm & Construction Machinery
Industrial Products
Transportation & Logistics
SEARCH
Home
NASDAQ:BGNE
NASDAQ:BGNE
Biotechnology
BGNE Stock Soars After Amgen Invests $2.7B in BeiGene
November 1, 2019
Health
This is Why BeiGene Ltd.’s Shares Rose Significantly on July 6, 2017
July 6, 2017
Health
Celsion Corp’s Stock Increased Almost 25% Today
July 5, 2017
LATEST NEWS
Investing News
Big Banks Set to Release Earnings
Investing News
JPMorgan Chase Stock Analysis
Investing News
Goldman Sachs Earnings Preview
Investing News
Top Vanguard ETFs to Hold Forever
Investing News
Earnings Reports to Watch This Week
Search
